Tiny Gold Particles Could Be Key to Developing a Treatment for Pancreatic Cancer

LW Newsfeed
A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease.

In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die of the disease, according to the National Institutes of Health. But research now being reported in ACS Nano could eventually lead to a new type of treatment based on gold nanoparticles.

Scientists have previously studied these tiny gold particles as a vehicle to carry chemotherapy drug molecules into tumors or as a target to enhance the impact of radiation on tumors. In addition, Priyabrata Mukherjee and colleagues previously found that gold nanoparticles themselves could limit tumor growth and metastasis in a model of ovarian cancer in mice. Read more . . .

image_printPrint Page

Conversation